share_log

HC Wainwright & Co. Maintains Buy on Acurx Pharmaceuticals, Raises Price Target to $14

Benzinga ·  Dec 15, 2023 06:36

HC Wainwright & Co. analyst Ed Arce maintains Acurx Pharmaceuticals (NASDAQ:ACXP) with a Buy and raises the price target from $13 to $14.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment